Search research articles
Contact Us
Filters
Showing results (191-200 of 214) with videos related to
Page
of 22
Sort By:
European Journal of Medicinal Chemistry
|
August 31, 2015
Unconventional Knoevenagel-type indoles: Synthesis and cell-based studies for the identification of pro-apoptotic agents
Andrea Spallarossa, Chiara Caneva, Matteo Caviglia, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 28, 2016
Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents
Annalaura Brai, Roberta Fazi, Cristina Tintori, et al.
Journal of Medicinal Chemistry
|
June 20, 2017
Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 Agents
Valeria Famiglini, Giuseppe La Regina, Antonio Coluccia, et al.
Journal of Medicinal Chemistry
|
January 26, 2017
Discovery of Multitarget Agents Active as Broad-Spectrum Antivirals and Correctors of Cystic Fibrosis Transmembrane Conductance Regulator for Associated Pulmonary Diseases
Sabrina Tassini, Liang Sun, Kristina Lanko, et al.
Journal of Medicinal Chemistry
|
January 28, 2009
Specific targeting of highly conserved residues in the HIV-1 reverse transcriptase primer grip region. 2. Stereoselective interaction to overcome the effects of drug resistant mutations
Stefania Butini, Margherita Brindisi, Sandro Cosconati, et al.
Journal of Medicinal Chemistry
|
January 15, 2009
Discovery of chiral cyclopropyl dihydro-alkylthio-benzyl-oxopyrimidine (S-DABO) derivatives as potent HIV-1 reverse transcriptase inhibitors with high activity against clinically relevant mutants
Marco Radi, Giovanni Maga, Maddalena Alongi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
June 9, 2025
Exploring structure-activity relationships of pyrrolyl diketo acid derivatives as non-nucleoside inhibitors of terminal deoxynucleotidyl transferase enzyme
Valentina Noemi Madia, Nadia Garibaldi, Davide Ialongo, et al.
Journal of Medicinal Chemistry
|
November 11, 2005
Specific targeting highly conserved residues in the HIV-1 reverse transcriptase primer grip region. Design, synthesis, and biological evaluation of novel, potent, and broad spectrum NNRTIs with antiviral activity
Caterina Fattorusso, Sandra Gemma, Stefania Butini, et al.
Journal of Medicinal Chemistry
|
February 23, 2016
Development and in Vitro Evaluation of a Microbicide Gel Formulation for a Novel Non-Nucleoside Reverse Transcriptase Inhibitor Belonging to the N-Dihydroalkyloxybenzyloxopyrimidines (N-DABOs) Family
Cristina Tintori, Annalaura Brai, Maria Chiara Dasso Lang, et al.
European Journal of Medicinal Chemistry
|
September 5, 2020
New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains
Marianna Nalli, Jorge I Armijos Rivera, Domiziana Masci, et al.
Page
of 22
Search research articles
Search
Showing results (191-200 of 214) with videos related to
Sort By:
Page
of 22
European Journal of Medicinal Chemistry
|
August 31, 2015
Unconventional Knoevenagel-type indoles: Synthesis and cell-based studies for the identification of pro-apoptotic agents
Andrea Spallarossa, Chiara Caneva, Matteo Caviglia, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 28, 2016
Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents
Annalaura Brai, Roberta Fazi, Cristina Tintori, et al.
Journal of Medicinal Chemistry
|
June 20, 2017
Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 Agents
Valeria Famiglini, Giuseppe La Regina, Antonio Coluccia, et al.
Journal of Medicinal Chemistry
|
January 26, 2017
Discovery of Multitarget Agents Active as Broad-Spectrum Antivirals and Correctors of Cystic Fibrosis Transmembrane Conductance Regulator for Associated Pulmonary Diseases
Sabrina Tassini, Liang Sun, Kristina Lanko, et al.
Journal of Medicinal Chemistry
|
January 28, 2009
Specific targeting of highly conserved residues in the HIV-1 reverse transcriptase primer grip region. 2. Stereoselective interaction to overcome the effects of drug resistant mutations
Stefania Butini, Margherita Brindisi, Sandro Cosconati, et al.
Journal of Medicinal Chemistry
|
January 15, 2009
Discovery of chiral cyclopropyl dihydro-alkylthio-benzyl-oxopyrimidine (S-DABO) derivatives as potent HIV-1 reverse transcriptase inhibitors with high activity against clinically relevant mutants
Marco Radi, Giovanni Maga, Maddalena Alongi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
June 9, 2025
Exploring structure-activity relationships of pyrrolyl diketo acid derivatives as non-nucleoside inhibitors of terminal deoxynucleotidyl transferase enzyme
Valentina Noemi Madia, Nadia Garibaldi, Davide Ialongo, et al.
Journal of Medicinal Chemistry
|
November 11, 2005
Specific targeting highly conserved residues in the HIV-1 reverse transcriptase primer grip region. Design, synthesis, and biological evaluation of novel, potent, and broad spectrum NNRTIs with antiviral activity
Caterina Fattorusso, Sandra Gemma, Stefania Butini, et al.
Journal of Medicinal Chemistry
|
February 23, 2016
Development and in Vitro Evaluation of a Microbicide Gel Formulation for a Novel Non-Nucleoside Reverse Transcriptase Inhibitor Belonging to the N-Dihydroalkyloxybenzyloxopyrimidines (N-DABOs) Family
Cristina Tintori, Annalaura Brai, Maria Chiara Dasso Lang, et al.
European Journal of Medicinal Chemistry
|
September 5, 2020
New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains
Marianna Nalli, Jorge I Armijos Rivera, Domiziana Masci, et al.
Page
of 22